KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Amgen (AMGN) over the last 15 years, with Q4 2024 value amounting to $700000.0.

  • Amgen's Treasury Shares changed N/A to $700000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $700000.0, marking a year-over-year change of. This contributed to the annual value of $700000.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Amgen's Treasury Shares stood at $700000.0.
  • Amgen's Treasury Shares' 5-year high stood at $26.1 million during Q4 2022, with a 5-year trough of $700000.0 in Q4 2024.
  • Over the past 4 years, Amgen's median Treasury Shares value was $4.4 million (recorded in 2020), while the average stood at $9.5 million.
  • In the last 5 years, Amgen's Treasury Shares crashed by 8015.27% in 2020 and then surged by 56486.49% in 2022.
  • Over the past 4 years, Amgen's Treasury Shares (Quarter) stood at $15.2 million in 2020, then skyrocketed by 42.76% to $21.7 million in 2021, then rose by 20.28% to $26.1 million in 2022, then tumbled by 97.32% to $700000.0 in 2024.
  • Its Treasury Shares stands at $700000.0 for Q4 2024, versus $26.1 million for Q4 2022 and $1.5 million for Q3 2022.